30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Vericel Corp (VCEL)

Track

Over the last 90 days, Vericel Corp. has seen a net insider selling of $327,425, with 18 transactions recorded. Notably, several executives, including Jonathan Mark Hopper and Kevin F. McLaughlin, have engaged in planned and proposed sales. The company's stock has experienced a 24.6% increase in the past 90 days.
Stock chart
Ticker: VCEL Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Flynn Sean C.
Officer
1 sale — total 100,000 USD
Proposed sale 18 Jun 2026
Value US$766,537.91 | Price 455.22 | Shares 32,938
Proposed sale 18 Jun 2026
Value US$3,330,215.63 | Price 438.41 | Shares 85,889
Planned sale 2 Jun 2026
Value US$100,000.00 | Price 35.00 | Shares 1,000
Proposed sale 2 Jun 2026
Value US$100,000.00 | Price 35.00 | Shares 1,000
Planned sale 13 May 2026
Value US$114,870.00 | Price 32.82 | Shares 3,500
Planned sale 13 May 2026
Value US$114,905.00 | Price 32.83 | Shares 3,500
Proposed sale 13 May 2026
Value US$227,990.00 | Price 32.57 | Shares 7,000
Sale 11 May 2026
Value US$244,800.00 | Price 32.64 | Shares 7,500
Sale 11 May 2026
Value US$82,625.00 | Price 33.05 | Shares 2,500
Proposed sale 11 May 2026
Value US$327,425.00 | Price 32.74 | Shares 10,000
Planned sale 7 May 2026
Value US$57,591.00 | Price 40.50 | Shares 1,422
Proposed sale 7 May 2026
Value US$57,591.00 | Price 40.50 | Shares 1,422
Planned sale 7 May 2026
Value US$202,500.00 | Price 40.50 | Shares 5,000
Proposed sale 7 May 2026
Value US$202,500.00 | Price 40.50 | Shares 5,000
Planned sale 6 May 2026
Value US$130,454.00 | Price 38.00 | Shares 3,433
Proposed sale 6 May 2026
Value US$130,454.00 | Price 38.00 | Shares 3,433
Planned sale 2 Apr 2026
Value US$121,520.00 | Price 35.00 | Shares 3,472
Proposed sale 2 Apr 2026
Value US$121,520.00 | Price 35.00 | Shares 3,472
Planned sale 23 Mar 2026
Value US$486,150.00 | Price 32.41 | Shares 15,000
Proposed sale 23 Mar 2026
Value US$486,162.53 | Price 32.41 | Shares 15,000
Planned sale 2 Mar 2026
Value US$530,400.00 | Price 35.36 | Shares 15,000
Planned sale 2 Mar 2026
Value US$223,129.75 | Price 34.75 | Shares 6,421
Proposed sale 2 Mar 2026
Value US$753,508.67 | Price 35.18 | Shares 21,421
Planned sale 2 Mar 2026
Value US$363,766.50 | Price 35.30 | Shares 10,305
Proposed sale 2 Mar 2026
Value US$363,749.02 | Price 35.30 | Shares 10,305
Planned sale 11 Feb 2026
Value US$242,620.00 | Price 34.66 | Shares 7,000
Proposed sale 11 Feb 2026
Value US$249,340.00 | Price 35.62 | Shares 7,000
Planned sale 7 Jan 2026
Value US$404,800.00 | Price 40.48 | Shares 10,000
Proposed sale 7 Jan 2026
Value US$404,832.95 | Price 40.48 | Shares 10,000
Sale 3 Dec 2025
Value US$94,575.00 | Price 37.83 | Shares 2,500
Proposed sale 3 Dec 2025
Value US$94,575.00 | Price 37.83 | Shares 2,500
Sale 2 Dec 2025
Value US$94,925.00 | Price 37.97 | Shares 2,500
Proposed sale 2 Dec 2025
Value US$94,918.75 | Price 37.97 | Shares 2,500
Planned sale 2 Dec 2025
Value US$64,659.28 | Price 39.14 | Shares 1,652
Proposed sale 2 Dec 2025
Value US$64,659.28 | Price 39.14 | Shares 1,652
Planned sale 11 Nov 2025
Value US$106,763.22 | Price 40.41 | Shares 2,642
Proposed sale 11 Nov 2025
Value US$106,759.79 | Price 40.41 | Shares 2,642
Planned sale 10 Nov 2025
Value US$270,130.00 | Price 38.59 | Shares 7,000
Proposed sale 10 Nov 2025
Value US$277,970.00 | Price 39.71 | Shares 7,000
Planned sale 6 Nov 2025
Value US$297,778.26 | Price 40.47 | Shares 7,358
Proposed sale 6 Nov 2025
Value US$297,774.72 | Price 40.47 | Shares 7,358
Planned sale 2 Sep 2025
Value US$357,700.00 | Price 35.77 | Shares 10,000
Proposed sale 2 Sep 2025
Value US$357,700.00 | Price 35.77 | Shares 10,000
Planned sale 6 Aug 2025
Value US$251,440.00 | Price 35.92 | Shares 7,000
Proposed sale 6 Aug 2025
Value US$251,456.85 | Price 35.92 | Shares 7,000
Planned sale 2 Jun 2025
Value US$400,900.00 | Price 40.09 | Shares 10,000
Proposed sale 2 Jun 2025
Value US$411,300.00 | Price 41.13 | Shares 10,000
Proposed sale 30 May 2025
Value US$551,250.00 | Price 42.00 | Shares 13,125
Planned sale 15 May 2025
Value US$584,036.39 | Price 41.53 | Shares 14,063
Proposed sale 15 May 2025
Value US$594,302.38 | Price 42.26 | Shares 14,063
Planned sale 14 May 2025
Value US$594,119.50 | Price 42.25 | Shares 14,062
Proposed sale 14 May 2025
Value US$608,743.98 | Price 43.29 | Shares 14,062
Planned sale 7 May 2025
Value US$279,860.00 | Price 39.98 | Shares 7,000
Proposed sale 7 May 2025
Value US$279,877.71 | Price 39.98 | Shares 7,000
Planned sale 10 Apr 2025
Value US$1,040,966.50 | Price 41.89 | Shares 24,850
Proposed sale 10 Apr 2025
Value US$1,040,865.27 | Price 41.89 | Shares 24,850
Planned sale 9 Apr 2025
Value US$1,021,583.50 | Price 41.11 | Shares 24,850
Proposed sale 9 Apr 2025
Value US$1,021,685.62 | Price 41.11 | Shares 24,850
Planned sale 13 Mar 2025
Value US$1,217,381.76 | Price 45.78 | Shares 26,592
Proposed sale 13 Mar 2025
Value US$1,217,280.93 | Price 45.78 | Shares 26,592
Planned sale 12 Mar 2025
Value US$1,231,429.21 | Price 46.31 | Shares 26,591
Proposed sale 12 Mar 2025
Value US$1,231,363.91 | Price 46.31 | Shares 26,591
Planned sale 3 Mar 2025
Value US$495,200.00 | Price 49.52 | Shares 10,000
Proposed sale 3 Mar 2025
Value US$512,000.00 | Price 51.20 | Shares 10,000
Planned sale 3 Mar 2025
Value US$445,770.00 | Price 49.53 | Shares 9,000
Proposed sale 3 Mar 2025
Value US$460,800.00 | Price 51.20 | Shares 9,000
Planned sale 3 Mar 2025
Value US$445,770.00 | Price 49.53 | Shares 9,000
Proposed sale 3 Mar 2025
Value US$460,800.00 | Price 51.20 | Shares 9,000
Planned sale 3 Mar 2025
Value US$495,300.00 | Price 49.53 | Shares 10,000
Proposed sale 3 Mar 2025
Value US$512,000.00 | Price 51.20 | Shares 10,000
Planned sale 25 Feb 2025
Value US$59,203.59 | Price 52.07 | Shares 1,137
Proposed sale 25 Feb 2025
Value US$59,203.59 | Price 52.07 | Shares 1,137
Planned sale 25 Feb 2025
Value US$86,904.83 | Price 52.07 | Shares 1,669
Proposed sale 25 Feb 2025
Value US$86,904.83 | Price 52.07 | Shares 1,669
Planned sale 20 Feb 2025
Value US$219,822.20 | Price 57.32 | Shares 3,835
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-18 2026-06-18 PrS Proposed sale
Flynn Sean C.

Officer

Officer
32,938
455.22
US$766,538 		32,938 455.22 US$766,538
2026-06-18 2026-06-18 PrS Proposed sale
Halpin Michael

Officer

Officer
85,889
438.41
US$3,330,216 		85,889 438.41 US$3,330,216
2026-06-04 2026-06-02 PlS Planned sale
Hopper Jonathan Mark

Chief Medical Officer

Officer
88,454 -5.0%
350.20
US$2,729,187 		88,454 -5.0% 350.20 US$2,729,187
2026-06-02 2026-06-02 PrS Proposed sale
Hopper Jonathan Mark

Officer

Officer
1,000
35.00
US$100,000 		1,000 35.00 US$100,000
2026-05-15 2026-05-13 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F
Non-Executive Director
3,500 -16.1%
32.82
US$114,870 		3,500 -16.1% 32.82 US$114,870
2026-05-15 2026-05-13 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F
Non-Executive Director
3,500 -16.1%
32.83
US$114,905 		3,500 -16.1% 32.83 US$114,905
2026-05-13 2026-05-13 PrS Proposed sale
0.6
MCLAUGHLIN KEVIN F

Director

Non-Executive Director
7,000
32.57
US$227,990 		7,000 32.57 US$227,990
2026-05-13 2026-05-11 S Sale
2.6
Wotton Paul K
Non-Executive Director
7,500 -28.5%
32.64
US$244,800 		7,500 -28.5% 32.64 US$244,800
2026-05-13 2026-05-11 S Sale
2.6
Wotton Paul K
Non-Executive Director
2,500 -8.7%
33.05
US$82,625 		2,500 -8.7% 33.05 US$82,625
2026-05-11 2026-05-11 PrS Proposed sale
2.6
Wotton Paul K

Director

Non-Executive Director
10,000
32.74
US$327,425 		10,000 32.74 US$327,425
2026-05-08 2026-05-07 PlS Planned sale
SIEGAL JONATHAN

Principal Accounting Officer

Officer
1,422 -56.0%
40.50
US$57,591 		1,422 -56.0% 40.50 US$57,591
2026-05-08 2026-05-07 PlS Planned sale
Mara Joseph Anthony Jr

Chief Financial Officer

Officer
5,000 -19.2%
40.50
US$202,500 		5,000 -19.2% 40.50 US$202,500
2026-05-07 2026-05-07 PrS Proposed sale
SIEGAL JONATHAN

Officer

Officer
1,422
40.50
US$57,591 		1,422 40.50 US$57,591
2026-05-07 2026-05-07 PrS Proposed sale
Mara Joseph Anthony Jr

Officer

Officer
5,000
40.50
US$202,500 		5,000 40.50 US$202,500
2026-05-08 2026-05-06 PlS Planned sale
SIEGAL JONATHAN

Principal Accounting Officer

Officer
3,433 -57.5%
38.00
US$130,454 		3,433 -57.5% 38.00 US$130,454
2026-05-06 2026-05-06 PrS Proposed sale
SIEGAL JONATHAN

Officer

Officer
3,433
38.00
US$130,454 		3,433 38.00 US$130,454
2026-04-06 2026-04-02 PlS Planned sale
Hopper Jonathan Mark

Chief Medical Officer

Officer
3,472 -4.4%
35.00
US$121,520 		3,472 -4.4% 35.00 US$121,520
2026-04-02 2026-04-02 PrS Proposed sale
Hopper Jonathan Mark

Officer

Officer
3,472
35.00
US$121,520 		3,472 35.00 US$121,520
2026-03-25 2026-03-23 PlS Planned sale
Hagen Heidi
Non-Executive Director
15,000 -32.0%
32.41
US$486,150 		15,000 -32.0% 32.41 US$486,150
2026-03-23 2026-03-23 PrS Proposed sale
Hagen Heidi

Director

Non-Executive Director
15,000
32.41
US$486,163 		15,000 32.41 US$486,163
2026-03-04 2026-03-02 PlS Planned sale
Flynn Sean C.

Chief Legal Officer

Officer
15,000 -92.2%
35.36
US$530,400 		15,000 -92.2% 35.36 US$530,400
2026-03-04 2026-03-02 PlS Planned sale
Flynn Sean C.

Chief Legal Officer

Officer
6,421 -83.6%
34.75
US$223,130 		6,421 -83.6% 34.75 US$223,130
2026-03-04 2026-03-02 PlS Planned sale
Halpin Michael

Chief Operating Officer

Officer
10,305 -39.1%
35.30
US$363,766 		10,305 -39.1% 35.30 US$363,766
2026-03-02 2026-03-02 PrS Proposed sale
Flynn Sean C.

Officer

Officer
21,421
35.18
US$753,509 		21,421 35.18 US$753,509
2026-03-02 2026-03-02 PrS Proposed sale
Halpin Michael

Officer

Officer
10,305
35.30
US$363,749 		10,305 35.30 US$363,749
2026-02-13 2026-02-11 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F
Non-Executive Director
7,000 -31.7%
34.66
US$242,620 		7,000 -31.7% 34.66 US$242,620
2026-02-11 2026-02-11 PrS Proposed sale
0.6
MCLAUGHLIN KEVIN F

Director

Non-Executive Director
7,000
35.62
US$249,340 		7,000 35.62 US$249,340
2026-01-09 2026-01-07 PlS Planned sale
Halpin Michael

Chief Operating Officer

Officer
10,000 -38.3%
40.48
US$404,800 		10,000 -38.3% 40.48 US$404,800
2026-01-07 2026-01-07 PrS Proposed sale
Halpin Michael

Officer

Officer
10,000
40.48
US$404,833 		10,000 40.48 US$404,833
2025-12-04 2025-12-03 S Sale
2.6
Wotton Paul K
Non-Executive Director
2,500 -8.9%
37.83
US$94,575 		2,500 -8.9% 37.83 US$94,575
2025-12-03 2025-12-03 PrS Proposed sale
2.6
Wotton Paul K

Director

Non-Executive Director
2,500
37.83
US$94,575 		2,500 37.83 US$94,575
2025-12-04 2025-12-02 S Sale
2.6
Wotton Paul K
Non-Executive Director
2,500 -8.2%
37.97
US$94,925 		2,500 -8.2% 37.97 US$94,925
2025-12-04 2025-12-02 PlS Planned sale
Hopper Jonathan Mark

Chief Medical Officer

Officer
1,652 -2.4%
39.14
US$64,659 		1,652 -2.4% 39.14 US$64,659
2025-12-02 2025-12-02 PrS Proposed sale
Hopper Jonathan Mark

Officer

Officer
1,652
39.14
US$64,659 		1,652 39.14 US$64,659
2025-12-02 2025-12-02 PrS Proposed sale
2.6
Wotton Paul K

Director

Non-Executive Director
2,500
37.97
US$94,919 		2,500 37.97 US$94,919
2025-11-13 2025-11-11 PlS Planned sale
Halpin Michael

Chief Operating Officer

Officer
2,642 -14.2%
40.41
US$106,763 		2,642 -14.2% 40.41 US$106,763
2025-11-12 2025-11-11 PrS Proposed sale
Halpin Michael

Officer

Officer
2,642
40.41
US$106,760 		2,642 40.41 US$106,760
2025-11-12 2025-11-10 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F
Non-Executive Director
7,000 -31.7%
38.59
US$270,130 		7,000 -31.7% 38.59 US$270,130
2025-11-10 2025-11-10 PrS Proposed sale
0.6
MCLAUGHLIN KEVIN F

Director

Non-Executive Director
7,000
39.71
US$277,970 		7,000 39.71 US$277,970
2025-11-10 2025-11-06 PlS Planned sale
Halpin Michael

Chief Operating Officer

Officer
7,358 -31.6%
40.47
US$297,778 		7,358 -31.6% 40.47 US$297,778
2025-11-06 2025-11-06 PrS Proposed sale
Halpin Michael

Officer

Officer
7,358
40.47
US$297,775 		7,358 40.47 US$297,775
2025-09-03 2025-09-02 PlS Planned sale
Hopper Jonathan Mark

Chief Medical Officer

Officer
10,000 -13.1%
35.77
US$357,700 		10,000 -13.1% 35.77 US$357,700
2025-09-02 2025-09-02 PrS Proposed sale
Hopper Jonathan Mark

Officer

Officer
10,000
35.77
US$357,700 		10,000 35.77 US$357,700
2025-08-08 2025-08-06 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F
Non-Executive Director
7,000 -31.7%
35.92
US$251,440 		7,000 -31.7% 35.92 US$251,440
2025-08-06 2025-08-06 PrS Proposed sale
0.6
MCLAUGHLIN KEVIN F

Director

Non-Executive Director
7,000
35.92
US$251,457 		7,000 35.92 US$251,457
2025-06-04 2025-06-02 PlS Planned sale
Hopper Jonathan Mark

Chief Medical Officer

Officer
10,000 -13.1%
40.09
US$400,900 		10,000 -13.1% 40.09 US$400,900
2025-06-02 2025-06-02 PrS Proposed sale
Hopper Jonathan Mark

Officer

Officer
10,000
41.13
US$411,300 		10,000 41.13 US$411,300
2025-05-30 2025-05-30 PrS Proposed sale
3.2
GILMAN STEVEN C

Former Director

Non-Executive Director
13,125
42.00
US$551,250 		13,125 42.00 US$551,250
2025-05-16 2025-05-15 PlS Planned sale
Colangelo Dominick

President and CEO

Executive Director
14,063 -5.1%
41.53
US$584,036 		14,063 -5.1% 41.53 US$584,036
2025-05-15 2025-05-15 PrS Proposed sale
Colangelo Dominick

Officer; Director

Executive Director
14,063
42.26
US$594,302 		14,063 42.26 US$594,302
2025-05-16 2025-05-14 PlS Planned sale
Colangelo Dominick

President and CEO

Executive Director
14,062 -5.1%
42.25
US$594,120 		14,062 -5.1% 42.25 US$594,120
2025-05-14 2025-05-14 PrS Proposed sale
Colangelo Dominick

Officer; Director

Executive Director
14,062
43.29
US$608,744 		14,062 43.29 US$608,744
2025-05-09 2025-05-07 PlS Planned sale
0.6
MCLAUGHLIN KEVIN F
Non-Executive Director
7,000 -31.7%
39.98
US$279,860 		7,000 -31.7% 39.98 US$279,860
2025-05-07 2025-05-07 PrS Proposed sale
0.6
MCLAUGHLIN KEVIN F

Director

Non-Executive Director
7,000
39.98
US$279,878 		7,000 39.98 US$279,878
2025-04-11 2025-04-10 PlS Planned sale
Colangelo Dominick

President and CEO

Executive Director
24,850 -8.7%
41.89
US$1,040,966 		24,850 -8.7% 41.89 US$1,040,966
2025-04-10 2025-04-10 PrS Proposed sale
Colangelo Dominick

Officer; Director

Executive Director
24,850
41.89
US$1,040,865 		24,850 41.89 US$1,040,865
2025-04-11 2025-04-09 PlS Planned sale
Colangelo Dominick

President and CEO

Executive Director
24,850 -8.7%
41.11
US$1,021,584 		24,850 -8.7% 41.11 US$1,021,584
2025-04-09 2025-04-09 PrS Proposed sale
Colangelo Dominick

Officer; Director

Executive Director
24,850
41.11
US$1,021,686 		24,850 41.11 US$1,021,686
2025-03-14 2025-03-13 PlS Planned sale
Colangelo Dominick

President and CEO

Executive Director
26,592 -9.3%
45.78
US$1,217,382 		26,592 -9.3% 45.78 US$1,217,382
2025-03-13 2025-03-13 PrS Proposed sale
Colangelo Dominick

Officer; Director

Executive Director
26,592
45.78
US$1,217,281 		26,592 45.78 US$1,217,281
2025-03-14 2025-03-12 PlS Planned sale
Colangelo Dominick

President and CEO

Executive Director
26,591 -9.3%
46.31
US$1,231,429 		26,591 -9.3% 46.31 US$1,231,429
2025-03-12 2025-03-12 PrS Proposed sale
Colangelo Dominick

Officer; Director

Executive Director
26,591
46.31
US$1,231,364 		26,591 46.31 US$1,231,364
2025-03-05 2025-03-03 PlS Planned sale
Halpin Michael

Chief Operating Officer

Officer
10,000 -39.2%
49.52
US$495,200 		10,000 -39.2% 49.52 US$495,200
2025-03-05 2025-03-03 PlS Planned sale
Mara Joseph Anthony Jr

Chief Financial Officer

Officer
9,000 -39.2%
49.53
US$445,770 		9,000 -39.2% 49.53 US$445,770
2025-03-05 2025-03-03 PlS Planned sale
Hagen Heidi
Non-Executive Director
9,000 -23.9%
49.53
US$445,770 		9,000 -23.9% 49.53 US$445,770
2025-03-05 2025-03-03 PlS Planned sale
Hopper Jonathan Mark

Chief Medical Officer

Officer
10,000 -13.1%
49.53
US$495,300 		10,000 -13.1% 49.53 US$495,300
2025-03-03 2025-03-03 PrS Proposed sale
Hagen Heidi

Director

Non-Executive Director
9,000
51.20
US$460,800 		9,000 51.20 US$460,800
2025-03-03 2025-03-03 PrS Proposed sale
Hopper Jonathan Mark

Officer

Officer
10,000
51.20
US$512,000 		10,000 51.20 US$512,000
2025-03-03 2025-03-03 PrS Proposed sale
Mara Joseph Anthony Jr

Officer

Officer
9,000
51.20
US$460,800 		9,000 51.20 US$460,800
2025-03-03 2025-03-03 PrS Proposed sale
Halpin Michael

Officer

Officer
10,000
51.20
US$512,000 		10,000 51.20 US$512,000
2025-02-26 2025-02-25 PlS Planned sale
SIEGAL JONATHAN

Principal Accounting Officer

Officer
1,137 -48.5%
52.07
US$59,204 		1,137 -48.5% 52.07 US$59,204
2025-02-26 2025-02-25 PlS Planned sale
Flynn Sean C.

Chief Legal Officer

Officer
1,669 -68.8%
52.07
US$86,905 		1,669 -68.8% 52.07 US$86,905
2025-02-25 2025-02-25 PrS Proposed sale
Flynn Sean C.

Officer

Officer
1,669
52.07
US$86,905 		1,669 52.07 US$86,905
2025-02-25 2025-02-25 PrS Proposed sale
SIEGAL JONATHAN

Officer

Officer
1,137
52.07
US$59,204 		1,137 52.07 US$59,204
2025-02-24 2025-02-20 PlS Planned sale
Flynn Sean C.

Chief Legal Officer

Officer
3,835 -83.5%
57.32
US$219,822 		3,835 -83.5% 57.32 US$219,822
Explore more

More insider trading research around Vericel Corp

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America